Cargando…

BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity

Pulmonary non-tuberculous mycobacterial (NTM) infections particularly caused by Mycobacterium avium complex (MAC) and Mycobacterium abscessus (MAB) are becoming major health problems in the U.S. New therapies or vaccines which will help prevent the disease, shorten treatment duration and/or increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abate, Getahun, Hamzabegovic, Fahreta, Eickhoff, Christopher S., Hoft, Daniel F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389677/ https://www.ncbi.nlm.nih.gov/pubmed/30837992 http://dx.doi.org/10.3389/fimmu.2019.00234

Ejemplares similares

Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signatures
por: Hamzabegovic, Fahreta, et al.
Publicado: (2020)

Impact of BCG vaccination on the repertoire of human γδ T cell receptors
por: Xia, Mei, et al.
Publicado: (2023)

Diagnosis and Management of Pulmonary NTM with a Focus on Mycobacterium avium Complex and Mycobacterium abscessus: Challenges and Prospects
por: Hendrix, Christian, et al.
Publicado: (2022)

BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
por: Covián, Camila, et al.
Publicado: (2019)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
por: Soto, Jorge A., et al.
Publicado: (2018)

Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19
por: Du, Jingli, et al.
Publicado: (2023)

Does BCG vaccination protect against infection with M. tuberculosis?
por: Pelzer, P. T., et al.
Publicado: (2022)

Optimizing the Boosting Schedule of Subunit Vaccines Consisting of BCG and “Non-BCG” Antigens to Induce Long-Term Immune Memory
por: Lv, Wei, et al.
Publicado: (2022)

Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
por: Diogo, Gil R., et al.
Publicado: (2019)

Virulence-Associated Secretion in Mycobacterium abscessus
por: Bar-Oz, Michal, et al.
Publicado: (2022)

Immunotherapy for tuberculosis: future prospects
por: Abate, Getahun, et al.
Publicado: (2016)

Granzyme A Produced by γ(9)δ(2) T Cells Activates ER Stress Responses and ATP Production, and Protects Against Intracellular Mycobacterial Replication Independent of Enzymatic Activity
por: Rasi, Valerio, et al.
Publicado: (2021)

Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory
por: da Costa, Adeliane Castro, et al.
Publicado: (2014)

Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial
por: dos Anjos, Laura Raniere Borges, et al.
Publicado: (2022)

Protective RNA nanovaccines against Mycobacterium avium subspecies hominissuis
por: Touray, Bubacarr J.B., et al.
Publicado: (2023)

Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques
por: Sarfas, Charlotte, et al.
Publicado: (2021)

SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia
por: Merid, Yared, et al.
Publicado: (2023)

BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity
por: Eggenhuizen, Peter J., et al.
Publicado: (2021)

Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination
por: Messina, Nicole L., et al.
Publicado: (2023)

A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice
por: Bai, Shimeng, et al.
Publicado: (2023)

Influenza Viruses: Innate Immunity and mRNA Vaccines
por: Lee, SangJoon, et al.
Publicado: (2021)

Proposing BCG Vaccination for Mycobacterium avium ss. paratuberculosis (MAP) Associated Autoimmune Diseases
por: Dow, Coad Thomas
Publicado: (2020)

Immunotherapy With 5, 15-DPP Mediates Macrophage M1 Polarization and Modulates Subsequent Mycobacterium tuberculosis Infectivity in rBCG30 Immunized Mice
por: Ahmad, Faraz, et al.
Publicado: (2021)

General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
por: To, Kimberly, et al.
Publicado: (2020)

Corrigendum: A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice
por: Bai, Shimeng, et al.
Publicado: (2023)

The BCG Vaccine for COVID-19: First Verdict and Future Directions
por: Gonzalez-Perez, Maria, et al.
Publicado: (2021)

The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues
por: Gong, Wenping, et al.
Publicado: (2022)

A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19
por: Singh, Shivani, et al.
Publicado: (2022)

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023)

Protective Value of BCG Vaccination
Publicado: (1950)

Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against Mycobacterium tuberculosis in mice
por: Ning, Huanhuan, et al.
Publicado: (2022)

Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis
por: Festjens, Nele, et al.
Publicado: (2011)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge
por: Morrison, Alexandra L., et al.
Publicado: (2023)

Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates
por: White, Andrew D., et al.
Publicado: (2023)

Mycobacterium abscessus—Bronchial Epithelial Cells Cross-Talk Through Type I Interferon Signaling
por: Zhang, Chongxu, et al.
Publicado: (2019)

An mRNA vaccine against rabies provides strong and durable protection in mice
por: Li, Miao, et al.
Publicado: (2023)

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
por: Hoft, Daniel F., et al.
Publicado: (2016)

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination
por: You, Weiqiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iv4vapb1rb9g8uq4p3ba8lr3qe